70
Views
5
CrossRef citations to date
0
Altmetric
Research Article

In vivo Heparan Sulfate Treatment Alters the Immune Response of Normal and LLC-Bearing Mice

, , &
Pages 67-79 | Published online: 08 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Vishnu Priya Murali & Girija Kuttan. (2016) Curculigoside augments cell-mediated immune responses in metastatic tumor-bearing animals. Immunopharmacology and Immunotoxicology 38:4, pages 264-269.
Read now
Rashid M. Rashid, John M. Lee, Jawed Fareed & M. Rita I. Young. (2007) In vitro Heparan Sulfate Modulates the Immune Responses of Normal and Tumor-Bearing Mice. Immunological Investigations 36:2, pages 183-201.
Read now

Articles from other publishers (3)

Sandrine Gulberti, Xianqing Mao, Catherine Bui & Sylvie Fournel-Gigleux. (2020) The role of heparan sulfate maturation in cancer: A focus on the 3O-sulfation and the enigmatic 3O-sulfotransferases (HS3STs). Seminars in Cancer Biology 62, pages 68-85.
Crossref
Rodrigo Abreu, Lauren Essler, Allyson Loy, Frederick Quinn & Pramod Giri. (2018) Heparin inhibits intracellular Mycobacterium tuberculosis bacterial replication by reducing iron levels in human macrophages. Scientific Reports 8:1.
Crossref
K. Sheeja & G. Kuttan. (2016) Modulation of Natural Killer Cell Activity, Antibody-Dependent Cellular Cytotoxicity, and Antibody-Dependent Complement-Mediated Cytotoxicity by Andrographolide in Normal and Ehrlich Ascites Carcinoma-Bearing Mice. Integrative Cancer Therapies 6:1, pages 66-73.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.